title: Levels of lipid peroxidation in human plasma and erythrocytes: comparison between fatty acids and cholesterol.
abstract: Lipid peroxidation has gained renewed attention with increasing evidence showing its biological role in producing toxic compounds and cellular signaling mediators. The assessment of lipid peroxidation levels in vivo is difficult partly because lipids are oxidized by different oxidants by different mechanisms to give versatile types of products, which may undergo metabolism and secondary reactions. In the present study, total hydroxyoctadecadienoic acids (tHODE) and 7alpha- and 7beta-hydroxycholesterol (t7-OHCh) from 44 healthy human subjects were assessed as biomarkers after reduction with sodium borohydride followed by saponification with potassium hydroxide comparing with the prevailing standard 8-isoprostaglandin F(2alpha) (t8-iso-PGF(2alpha)). The average concentrations of tHODE, total 8-isoprostaglandin F(2alpha) (t8-iso-PGF(2alpha)), t7alpha-OHCh, and t7beta-OHCh were 203, 0.727, 87.1, and 156 nmol/l plasma and 1,917, 12.8, 1,372, and 3,854 nmol/l packed erythrocytes, respectively. The ratios of tHODE and t7-OHCh to the parent substrates were 194 and 3,519 micromol tHODE/mol linoleates and 40.9 and 686 micromol t7-OHCh/mol cholesterol in plasma and erythrocytes, respectively. It was found that (1) t7-OHCh in blood was unexpectedly high, as high as or even higher than tHODE, (2) the amounts of tHODE was more than 100 fold higher than t8-iso-PGF(2alpha) (3) the level of lipid oxidation products in erythrocytes was higher than that in plasma, and (4) lipid peroxidation products level tended to increase while antioxidant level decrease with age. These products may be used as potential biomarker for assessment of lipid peroxidation and oxidative stress in vivo.
authors.affiliation: Human Stress Signal Research Center, National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorigaoka, Ikeda, Osaka, Japan. yoshida-ya@aist.go.jp
authors.forename: Yasukazu
authors.initials: Y
authors.lastname: Yoshida
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Saito
authors.forename: Mieko
authors.initials: M
authors.lastname: Hayakawa
authors.forename: Yoko
authors.initials: Y
authors.lastname: Habuchi
authors.forename: Yasuharu
authors.initials: Y
authors.lastname: Imai
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Sawai
authors.forename: Etsuo
authors.initials: E
authors.lastname: Niki
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000975:Antioxidants / Q000032:analysis; D015415:Biomarkers / Q000097:blood; D002784:Cholesterol / Q000097:blood* / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D005227:Fatty Acids / Q000097:blood* / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000097:blood / Q000378:metabolism; D005260:Female; D006801:Humans; D006888:Hydroxycholesterols / Q000097:blood / Q000378:metabolism; D015227:Lipid Peroxidation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D006888:Hydroxycholesterols; C495366:hydroxyoctadecadienoic acid; C011724:cholest-5-en-3 beta,7 alpha-diol; D002784:Cholesterol